You are here
Eu Yan Sang seeking alternative prescription with SGX exit?
Late trading suspension sets market abuzz with talk of delisting offer; stock jumps 10 per cent before suspension
Eu Yan Sang group CEO Richard Eu. The potential privatisation attempt by the firm is believed to be handled by Credit Suisse.
FILE PHOTO
Singapore
THE exodus of consumer stocks from the Singapore bourse looks set to continue.
Trading in the shares of traditional Chinese medicine (TCM) retailer Eu Yan Sang International remained halted on Wednesday amid growing market talk that a move has been made to take it private
GAIN ACCESS TO ALL BT PREMIUM CONTENT:
Or get a 2-week FREE trial
Need help?
- CALL +65 6388 3838
- EMAIL btocs@sph.com.sg
